Your browser doesn't support javascript.
loading
EGFR and PI3K/m-TOR inhibitors: design, microwave assisted synthesis and anticancer activity of thiazole-coumarin hybrids.
Batran, Rasha Z; Ahmed, Eman Y; Awad, Hanem M; Ali, Korany A; Abdel Latif, Nehad A.
Affiliation
  • Batran RZ; Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt eyam_ha@yahoo.com nehad_km@yahoo.com.
  • Ahmed EY; Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt eyam_ha@yahoo.com nehad_km@yahoo.com.
  • Awad HM; Tanning Materials and Leather Technology Department, National Research Centre Dokki Cairo 12622 Egypt.
  • Ali KA; Applied Organic Chemistry Department, Advanced Materials and Nanotechnology Group, National Research Centre Dokki Cairo 12622 Egypt.
  • Abdel Latif NA; Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt eyam_ha@yahoo.com nehad_km@yahoo.com.
RSC Adv ; 13(42): 29070-29085, 2023 Oct 04.
Article in En | MEDLINE | ID: mdl-37800132
ABSTRACT
A series of thiazoline and thiazolidinone-based 4-hydroxycoumarin derivatives were synthesized using both conventional synthesis procedures and microwave-assisted techniques. The new compounds were evaluated for their cytotoxic effect against three human cancer cell lines; MCF-7, HCT-116 and HepG2 and one normal human cell line (BJ-1). The promising anti-proliferative compounds 2a, 2b, 6a and 6b were assessed for inhibiting EGFR and PI3K/mTOR. Compound 6a showed the highest inhibition activity towards the signaling pathway. The apoptotic effect and cell cycle arrest potential of derivative 6a were examined. Moreover, the molecular docking, physicochemical properties and pharmacokinetic parameters of the promising compound were investigated, as well.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: RSC Adv Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: RSC Adv Year: 2023 Document type: Article